Explore Our Latest News
and Press Releases

February 2026 Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development
February 2026 Caidya Strengthens European Growth Strategy and Appoints Mario Bautista as Head of Business Development, Europe
December 2025 Caidya’s Miles Pan Named to Legal 500 GC Powerlist China 2025
November 2025 Caidya Reimagines Next Generation Clinical Trial Innovation and Study Delivery with Medidata AI-Powered Experiences
September 2025 Caidya Appoints Dr. Bin Peng as Chair of its China Scientific Advisory Board
July 2025 Caidya’s John Wang Named Chair of China CDISC Coordinating Committee; Medidata Accreditation Underscores Data Management Excellence
March 2025 Caidya Strengthens Therapeutic Leadership: Names Adam Callahan Head of Oncology and Hematology
January 2025 Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion
January 2025 Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders
July 2024 Caidya Announces Leadership Transition: Barbara Lopez Kunz Named CEO
June 2024 Caidya Achieves Medidata Rave TSDV Accreditation, Enhancing Clinical Trial Efficiency and Data Integrity
April 2024 Caidya Expands Global Presence with the Establishment of Caidya Canada Limited and New Office in Toronto
January 2024 Caidya Welcomes Jay Roberts to its Board of Directors
July 2023 Caidya Wins CRO Leadership Award for Overall Capabilities
November 2022 Caidya Announces Appointment of Barbara Lopez Kunz to Board of Directors
October 2022 Clinipace Name Change: Introducing Caidya, a New Name for a Leading Global CRO
April 2021 CROs dMed and Clinipace merge to accelerate customer success